Directory
>
Guillaume Pfefer
Guillaume Pfefer
Chief Executive Officer Partner Senda Biosciences, A Flagship Pioneering Company | Flagship Pioneering
Boston, Massachusetts, United States
Guillaume Pfefer
Summary
Guillaume Pfefer is a seasoned biopharmaceutical executive with a wealth of experience spanning both large corporations and innovative start-ups. Currently serving as CEO Partner at Flagship Pioneering and CEO of Sail Biomedicines, he has a proven track record in transforming organizations from strategic resets to market leaders. His leadership at Kala Pharmaceuticals led to a successful IPO, driven by the initiation of multiple clinical trials. With a strong background in venture financing, he has raised significant capital for emerging technologies. Guillaume's strategic vision and ability to recruit top talent have consistently resulted in high-impact outcomes. He is also recognized for his role in the development and commercialization of vaccines, evidenced by his leadership in GSK's Shingrix project, which won multiple awards. His educational credentials include an MBA from The Wharton School and a PhD in Physics from Aix-Marseille University.
Guillaume Pfefer
Work Experience
Chief Executive Officer Partner Senda Biosciences, A Flagship Pioneering Company at
Flagship Pioneering
June 2020 - Present
General Manager Sanofi Pasteur Mexico at
Sanofi Pasteur
January 2010 - July 2012
Guillaume Pfefer
Education
Wharton School, Master Of Business Administration - Mba
ENSIC, National, School of Chemical Engineering, University of Nancy, Nancy, France, Master & Post Master Degrees
Aix-Marseille University, Doctor Of Philosophy - Phd
Frequently Asked Questions about Guillaume Pfefer
What is Guillaume Pfefer email address?
Guillaume Pfefer's primary email address is *********************@wharton.upenn.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Guillaume Pfefer work for?
Guillaume Pfefer is a Chief Executive Officer Partner Senda Biosciences, A Flagship Pioneering Company at Flagship Pioneering, a company specializing in Commercial physical research.
Where Guillaume Pfefer graduated from?
Guillaume Pfefer holds a degree in Finance & Entrepreunership from Wharton School.
How can I directly contact Guillaume Pfefer?
To contact Guillaume Pfefer directly, you can use the email address *********************@wharton.upenn.edu. Complete contact information is available upon registration with Muraena.
Who is Guillaume Pfefer?
Guillaume Pfefer is a seasoned biopharmaceutical executive with a wealth of experience spanning both large corporations and innovative start-ups. Currently serving as CEO Partner at Flagship Pioneering and CEO of Sail Biomedicines, he has a proven track record in transforming organizations from strategic resets to market leaders. His leadership at Kala Pharmaceuticals led to a successful IPO, driven by the initiation of multiple clinical trials. With a strong background in venture financing, he has raised significant capital for emerging technologies. Guillaume's strategic vision and ability to recruit top talent have consistently resulted in high-impact outcomes. He is also recognized for his role in the development and commercialization of vaccines, evidenced by his leadership in GSK's Shingrix project, which won multiple awards. His educational credentials include an MBA from The Wharton School and a PhD in Physics from Aix-Marseille University.
Guillaume`s contact details
*********************@wharton.upenn.edu
*******@flagshippioneering.com
Colleagues
Co-Founder and Board Member
General Partner
Managing Partner
Vice President, Strategy & Operations
Partner, Senior Vice President of Finance
Chief HR Officer and Executive Partner
VP, Intellectual Property Counsel
Origination Partner
Vice President, Talent Acquisition & HR Systems
Senior Vice President, Program Leadership & Portfolio Lead, Oncology and Immunology